Monday, September 12, 2016

BRIEF-Xencor doses first patient in blood cancer test

* Oncology bispecific program XmAb14045 for the treatment of

acute myeloid leukemia and other CD123-expressing hematologic

malignancies

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)